#Ireland #Dublin #Perimenopause #Wearable Device #Peri

Peri Launches Innovative Wearable Device for Perimenopause

On April 2, 2026, Peri, a company dedicated to women's health, unveiled a revolutionary wearable device aimed specifically at monitoring perimenopause. This cutting-edge gadget represents a significant advancement in women's health technology, enabling individuals to gain real-time insights about their bodies during a critical transition.

The device is designed to continuously track biometeric data, offering women an objective view of the physiological changes occurring in their bodies as they navigate through perimenopause. This innovative product not only aids women in understanding their symptoms better but also empowers them to make informed decisions regarding their healthcare.

A New Resource for Women's Health

Perimenopause is a phase that affects numerous women, bringing a variety of symptoms like hot flashes, sleep disruptions, anxiety, and joint pain. However, despite being one of the most prevalent health issues, it remains poorly understood and inadequately researched. Historically, clinical research has overlooked the inclusion of women, leading to a lack of standardized treatment protocols and effective communication regarding their health experiences.

Heidi Davis, co-founder and CEO of Peri, stated, "We built Peri to ensure that women can finally see what’s truly happening in their bodies, rather than relying on a system that has failed to address their unique needs." With this new device, women can take control of their health, as it provides them with data-driven insights on how their symptoms evolve over time.

Key Features of the Device

The Peri device is lightweight and discreet, designed to be worn continuously under the breast. Its unique placement allows for accurate monitoring of key symptoms, such as hot flashes and night sweats, unlike traditional wristbands or rings. The product has been five years in the making, with an artificial intelligence platform developed specifically for analyzing the continuous data gathered from users experiencing perimenopause.

Accompanying the wearable is a user-friendly app that translates raw data into actionable insights. Users receive personalized feedback about their symptoms, sleep patterns, mood, and activity levels, creating a comprehensive picture of their health on a weekly, monthly, and cyclical basis.

Beyond Symptom Management

Perimenopause is not just about short-term symptom relief; it represents a crucial period linked to long-term health outcomes. The data collected through Peri's device aims to build a health record that could identify potential health risks connected to heart health, bone density, and cognitive function years before they manifest as serious conditions.

The Peri kit, available for purchase at www.myperi.co for $449, includes the device, two rechargeable batteries, 20 adhesives for secure placement, a charger, and a USB cable. Additionally, the device is eligible for FSA and HSA payments, making it accessible for many women.

Conclusion

The launch of this wearable device marks a significant triumph in addressing the gaps in women's health care related to perimenopause. By providing continuous biometric data, Peri empowers women to take an active role in their health management, paving the way for more tailored and effective treatment options in the future. As the understanding of perimenopause evolves, this groundbreaking innovation will undoubtedly help transform women’s health experiences around the globe.